Market Updates

Concordix to Showcase Launch-Ready Product Concepts, Commercialization Support, and Expanded Patent Protection

The specialist in next-gen nutrient delivery has ore than 60 ready-to-launch concept products across leading health categories.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: zzzdim | Adobe Stock

Concordix, the patented chewable emulsion delivery technology from Vitux, will showcase how it can accelerate product launches with brand partners thanks to a series of strategic advancements. Additionally, a key U.S. patent covering the Concordix delivery technology has been granted an extension, reinforcing continued intellectual property protection and partner confidence for brands building on the Concordix platform.

The Concordix portfolio now includes more than 60 launch-ready concept products across priority health categories like longevity, immunity, children’s development, and general well-being. The portfolio features new vegan-friendly formulations alongside established delivery designs. Custom innovation projects will continue in parallel, allowing for tailored formulations.

Support for brands using the Concordix platform extends beyond manufacturing. Brand partners gain access to Concrodix’s marketing playbook designed to guide consumer messaging around delivery technology, benefits, and differentiation, along with customizable, consumer-facing launch assets.

Concordix features a patented chewable delivery system that improves bioavailability and consumer experience. The technology improves the taste of high-potency formulations, including combinations of oil- and water-soluble actives, which are difficult in conventional capsules, tablets, or gummies. The format engages digestion earlier and mirrors natural nutrient pathways, the company reported.

Extended IP Protection

Concordix has been granted an extension on a key U.S. patent that supports the delivery technology, reinforcing continued IP protection, market insulation, and brand partner confidence. Ongoing investment in clinical studies further substantiates the format’s bioavailability, delivery performance, and versatility with new active ingredients.

“Brands today are under pressure to move faster while still delivering products that work and resonate with consumers,” said Catherine Nardone, vice president of marketing. “By combining a patented delivery platform, launch-ready innovation, and commercialization support, Concordix helps partners go to market with confidence, without compromising on science or experience.”

To meet with Concordix, reach out to Catherine Nardone at [email protected]

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters